TOG Review (RCOG Journal)
MRCOG Part 2
Antenatal Care
Evolution in screening of Down syndrome
Key Statistics
- 30% — DR, maternal age alone (5% FPR)
- 60–75% — DR, 2nd-trimester biochemistry (5% FPR)
- 90% — DR, combined 1st-trimester test (5% FPR)
Don't-miss facts
-
Maternal age alone: 30% DR at 5% FPR
-
Second-trimester serum biochemistry: 60–75% DR at 5% FPR
-
First-trimester combined test (NT + biochemistry): 90% DR at 5% FPR
-
Cell-free DNA: 99% DR at 0.1% FPR — best performing, but currently expensive
-
Proposed feasible model: offer cfDNA contingent on first-line combined-test result, not as universal first-line test
-
Source is abstract-level only — verify details against full TOG article before relying on this for exam depth
Screening generations at a glance
Maternal age: 30% DR / 5% FPR 2nd-tri biochemistry: 60–75% DR / 5% FPR Combined test: 90% DR / 5% FPR
cfDNA: 99% DR / 0.1% FPR
Abbreviation Key
- DR — detection rate
- cfDNA — cell-free DNA
- FPR — false positive rate
- TOG — The Obstetrician & Gynaecologist
- NT — nuchal translucency
Source: Ashoor Al Mahri G, Nicolaides KH. Evolution in screening of Down syndrome. The Obstetrician & Gynaecologist 2019;21:51–57. doi:10.1111/tog.12534
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).